08
Dec
Tujoromajo Kasuto CHILDREN aged 12 years and older are now eligible to receive the Pfizer COVID-19 vaccines, as the Ministry of Health and Social Services (MoHSS) has decided to expand vaccination eligibility to children and adolescents aged 12-17 years. Vaccination reduces the risk of severe illness, hospitalisation and deaths due to COVID-19. The World Health Organisation (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that Pfizer/BionTech COVID-19 vaccine is suitable for use by persons aged 12 years and above. The same vaccine has been granted Emergency Use Authorisation by the US Food and Drug Administration (FDA) for use in…